SUPPLIER SPOTLIGHT

Dr. Reddy’s Laboratories: Sustainable, Affordable APIs and Digitisation

Dr. Reddy’s Laboratories, the global pharmaceutical company headquartered in Hyderabad, India, has been a key player in the pharma industry since its establishment in 1984.

Committed to ensuring access to affordable and innovative medicines, the company operates under the mantra, ‘Good Health Can’t Wait’. Dr. Reddy’s offers a comprehensive range of products and services, encompassing APIs, generics, branded generics, biosimilars, and OTC medications.

Ahead of CPHI 2023 we interviewed Kalpesh Kumar Modi, VP and Head of Europe API Sales, Dr. Reddy’s Laboratories to explain what makes them unique.

“We manufacture more than 200 APIs and specialise in complex APIs, including peptides, oncology, cardiovascular, and all other therapeutic categories.” says Kalpesh.

“Dr. Reddy’s is a vertically integrated pharma company that can support customers with formulation expertise, improving development processes and timelines, and have global regulatory teams facilitating filings and early market launches.” 

Dr Reddy’s is committed to ESG principles, employing ‘green chemistry’ to make API processes sustainable and work with suppliers who contribute to sustainable supply chain performance.

In 2023, the company recently became a ‘Water Positive‘ company, beating their 2025 target by two years.

“We were among the first Indian companies to build a zero liquid discharge infrastructure into all our facilities. We are delighted to say that we are not sending a single kilogramme of waste to any landfill.”

Kalpesh explains API Plus, an initiative for emerging markets where customers don’t have their own formulation facilities.

“The core objective of API Plus is to ensure that patients of those countries can access high-quality, affordable medicines. We cooperate with local partners and support them with expertise, formulation, and technology.”

Digitalisation is another major focus for Dr. Reddy’s, says Kalpesh. “We are leveraging Industry 4.0 technologies to streamline operations and enhance data accuracy.”

As an example of this, the company has created a platform called XCEED that enables customers to manage the complete inquiry and procurement process of Dr. Reddy’s APIs in real-time. 

Meet the Dr Reddy’s team at CPHI 2023 stand 4C30 or visit their website for more information.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.